Sonoma Pharmaceuticals, Inc.

SNOA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$3,035$3,605$5,374$5,236
Short-Term Investments$0$0$0$0
Receivables$2,703$2,602$3,763$2,405
Inventory$3,634$3,802$2,915$3,143
Other Curr. Assets$3,129$3,098$596$1,596
Total Curr. Assets$12,501$13,107$12,648$12,380
Property Plant & Equip (Net)$763$837$309$334
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$508$546$589$760
Other NC Assets$84$104$147$194
Total NC Assets$1,355$1,487$1,045$1,288
Other Assets$0$0$0$0
Total Assets$13,856$14,594$13,693$13,668
Liabilities
Payables$1,404$2,046$953$1,395
Short-Term Debt$144$235$278$90
Tax Payable$5,356$5,246$0$5,036
Deferred Revenue$750$731$641$302
Other Curr. Liab.-$3,332-$3,410$2,224-$3,120
Total Curr. Liab.$4,322$4,848$4,096$3,703
LT Debt$391$440$27$29
Deferred Rev, NC$0$4$17$30
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$5,356$5,250$5,142$5,036
Total NC Liab.$5,747$5,690$5,186$5,095
Other Liabilities$0$0$0$0
Cap. Leases$391$536$85$29
Total Liabilities$10,069$10,538$9,282$8,798
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$199,581-$199,047-$197,806-$197,030
AOCI-$3,365-$3,570-$4,376-$4,554
Other Equity$206,733$206,673$206,593$206,454
Total Equity$3,787$4,056$4,411$4,870
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$13,856$14,594$13,693$13,668
Net Debt-$2,500-$2,930-$5,069-$5,117
Sonoma Pharmaceuticals, Inc. (SNOA) Financial Statements & Key Stats | AlphaPilot